Clinical trial
Comparison of Mean Duration of Post Operative Analgesia Following QL-2 Block vs QL-3 Block Using Ropivacain 0.25% in Patients Undergoing Unilateral Inguinal Hernia Repair
NCT07200076 is registered in ClinicalTrials.gov with Quaid-e-Azam Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Mean Duration of Post Operative Analgesia Following QL-2 Block vs QL-3 Block Using Ropivacain 0.25% in Patients Undergoing Unilateral Inguinal Hernia Repair
- Lead sponsor
- Quaid-e-Azam Medical College
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2024
- Completion date
- January 28, 2025
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inguinal hernia unilateral